Firms

Elaia

Paris, France · Belgium

elaia.com

signal.nfx.com

goldi.ai

Elaia is a leading European full-stack venture capital firm specializing in digital and deep tech, headquartered in Paris, France. Founded in 2002, it partners with ambitious B2B technology entrepreneurs from pre-seed to Series B, focusing on AI, cybersecurity, techbio, and industrial innovation.

Founded: 2002
Type: Venture capital

Funds3

Deep Tech Seed 32026-03-122026-03-12€134M
DTS3 final close, EUR134m supersedes EUR60m March2024 first close and EUR120m target. Fund-specific preseed/seed EUR1m–13m tickets, not firmwide initial checks.
Digital Venture 52026-02-112026-02-11€120M
DV5 EUR120m FIRST CLOSE, not final size. Date from Maddyness 2026-02-11 reporting; official HTML undated. Fund-specific preseed–SeriesB tickets EUR1m–15m; mimic first investment, exact allocation unknown.
Digital Venture 42023-03-302023-03-30€200M
DV4 EUR200m final close reported 2023-03-30, supersedes earlier commitments/target.

Team

Investments

team@apexlogos.ai13 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and investment stages | Vehicle / metric | Amount and status | Dated supporting evidence and caveat | | --- | --- | --- | | Deep Tech Seed 3 (DTS3) | **€134 million final close**; first close was €60 million in March 2024 | Official release is dated **2026-03-12** in its [search-indexed PDF](https://www.elaia.com/wp-content/uploads/2026/03/DTS3-Final-Close-ENG.pdf); the [official HTML announcement](https://elaia.com/news/elaia-announces-final-close-of-dts3-at-134m) was directly read. The PDF itself returned a fetch error. This is a final close, superseding the early €120m target. | | Digital Venture 5 (DV5) | **€120 million first close**, not verified final size | [Official announcement](https://elaia.com/news/elaias-fifth-digital-venture-fund-dv5-announces-first-close-at-120m), HTML undated; [Maddyness, 2026-02-11](https://www.maddyness.com/2026/02/11/elaia-lance-un-nouveau-fonds-de-120-millions-deuros/) dates the first-close reporting. Official [PDF](https://www.elaia.com/wp-content/uploads/2026/02/DV5-First-Close-EN.pdf) was indexed but direct retrieval failed. No later final close verified. | | Digital Venture 4 (DV4) | **€200 million final close** | [EU-Startups, 2023-03-30](https://www.eu-startups.com/2023/03/elaia-closes-its-dv4-fund-at-e200-million-to-back-early-stage-b2b-tech-startups/). The historical [official PDF](https://www.elaia.com/wp-content/uploads/2023/03/DV4_PR_ENG.pdf) remains search-indexed but now redirects to a missing page. Earlier €120m commitments / €150m target are stale fundraising milestones, not final size. | | Firmwide AUM | **More than €1 billion**, reported with 2025 fundraising results | Lazard's [2026-06-16 announcement](https://www.lazardfreresgestion.com/fr/en_gb/about-us/news-and-press/funds-and-expertise/lazard-increases-stake-in-elaia-to-51) says Elaia raised €250m across funds in 2025 and surpassed €1bn AUM. Annual fundraising and AUM are separate metrics, neither an individual fund. | Latest-known individual vehicles checked are DTS3 and DV5; this is not a guarantee of exhaustive fund chronology. **DTS3 explicitly targets European B2B pre-seed and seed**, reporting investment amounts of €1m–€13m. **DV5 covers pre-seed through Series B** with stated tickets €1m–€15m for European B2B technology. These are fund-specific published ranges, not universally verified initial checks or whole-firm sweet spots. The broader homepage's pre-IPO positioning should not replace the early-stage mandates. DTS3's [official announcement](https://elaia.com/news/elaia-announces-final-close-of-dts3-at-134m) names computing, industry and life sciences as pillars; DV5's [official announcement](https://elaia.com/news/elaias-fifth-digital-venture-fund-dv5-announces-first-close-at-120m) supplies its stages and tickets. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Digital Venture 4 | EUR 200000000 | 2023-03-30 | | Digital Venture 5 | EUR 120000000 | 2026-02-11 | | Deep Tech Seed 3 | EUR 134000000 | 2026-03-12 |
team@apexlogos.ai14 hours ago
Match research 2026-10-06 / GoldiElaia / sha256:e4576ba144f2122ad4ffa1b1da7f9b9b6b8011b4b2cd5c8c2dbfe66f8673a81d / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. **SIM&CURE is verified brain-health/neurovascular adjacent technology.** NeuroNews reports on **2025-12-03** that it closed a **€10m series extension**, with historical investors **Elaia and IT Translation Investissement** participating alongside others. Its patient-specific simulations and digital twins support cerebral aneurysm endovascular procedure planning; additional software detects cerebral aneurysms from images. This has technical depth, but does not directly measure or stimulate neural activity. [NeuroNews International report](https://neuronewsinternational.com/simcure-raises-e10-million-to-advance-individualised-neurovascular-procedures/). The report attributes the technology descriptions to a company release; an independently fetched original release was not obtained. Elaia's contribution and original entry date are unknown; investor quotations support historical backing but not a specific seed date. **Excluded attribution lead:** Robeauté develops genuine brain microsurgical robotics, but its [2025 funding announcement](https://robeaute.com/news-updates/robeaute-raises-28-million-usd-to-transform-brain-health) names Plural, Cherry, Kindred, LocalGlobe, Think.Health, APEX Ventures and Brainlab, not Elaia. Therefore it is not assigned to Elaia. Searches covering Elaia plus neurotech, brain, Neurallys and Robeauté did not yield a verified direct neural-technology investment. Broad AI and ophthalmology exposure should not become a neurotech tag without specific evidence. ## Conflicts, gaps and later Adex review 1. Preserve exact ID `GoldiElaia`; manager identity is Elaia. Generic Goldi source links should be replaced or supplemented by specific original announcements when a later update is authorized. 2. Retain separate fund fields: DTS3 €134m final close; DV5 €120m first close; DV4 €200m final close; AUM >€1bn. Do not collapse them into one ambiguous “fund size.” No current DV5 target/final amount was verified. 3. The broader pre-IPO website language reflects platform positioning, including Lazard Elaia Capital; do not automatically attribute every joint-venture transaction to Elaia's existing funds. Majority ownership does not rename historical fund participations. 4. Snapshot has duplicate investment variants such as Proxima / Proxima Fusion / PROXIMA FUSION GMBH and Biophta entries. Later review should reconcile entities and dated rounds; this report makes no data edits. The snapshot's 2026 Proxima financing was not independently verified here and should not be copied solely from that baseline. 5. SIM&CURE's snapshot lacked an announcement date; dated reporting supports 2025-12-03 for the extension announcement. Label it neurovascular adjacent rather than asserting direct BCI exposure. Round stage is “series extension”; a specific Series A/B designation was not established. 6. Named investments here are representative verified examples, not an exhaustive portfolio audit. Missing individual investment amounts, exact legal fund vehicles for most deals, entry dates and exits should remain unknown rather than inferred. Undated pages were accessed 2026-10-06; PDF access failures are explicitly recorded above.
team@apexlogos.ai14 hours ago
Match research 2026-10-06 / GoldiElaia / sha256:e4576ba144f2122ad4ffa1b1da7f9b9b6b8011b4b2cd5c8c2dbfe66f8673a81d / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Elaia — GoldiElaia - **Exact Adex ID:** `GoldiElaia` (retain this URL ID, despite the Goldi prefix). - **Adex webpage:** https://adex.page/firms/GoldiElaia - **Research date / source access date:** 2026-10-06. - **Status:** Complete research review; findings only, no Adex/database edits. ## Identity and summary Elaia / Elaia Partners is the European digital and deep-tech venture firm represented by this record, rather than a separate firm named Goldi. Its current website presents a platform spanning pre-seed to pre-IPO, with scientific research partnerships and technology investing [official homepage, undated](https://elaia.com/). Actual fund mandates are narrower, as described below. Quantum computing, fusion, robotics and scientific drug discovery investments are verified. SIM&CURE is a verified neurovascular technology investment, but should be separated from direct neural interfaces or neuromodulation. Lazard announced a **51% ownership stake on June 16, 2026**, while stating that Elaia's investment decisions and existing funds would remain independently managed. This is ownership of the manager, not an investee financing or fund size. [Official Lazard announcement, 2026-06-16](https://www.lazardfreresgestion.com/fr/en_gb/about-us/news-and-press/funds-and-expertise/lazard-increases-stake-in-elaia-to-51). ## Starting evidence: Adex and NFX Signal The saved `data/research/_sources/GoldiElaia.adex.json` was retrieved 2026-10-06T19:29:04.507Z by read-only MCP Search. The exact record names Elaia, describes a Paris-based firm founded in 2002 supporting B2B technology from pre-seed to Series B, and supplies https://www.elaia.com/, https://signal.nfx.com/firms/elaia-partners and https://goldi.ai/intelligence/vc/elaia. Its investor profile has null minimum, maximum and sweet-spot checks. The snapshot lists extensive prior transactions, including Alice & Bob, Proxima Fusion, Biophta, Aqemia, mimic robotics and SIM&CURE. These are leads rather than verification. Generic https://goldi.ai/ citations, missing dates and duplicate company variants require review; the selected named transactions below have separate supporting evidence. [NFX Signal firm profile](https://signal.nfx.com/firms/elaia-partners) was directly read, not only search-indexed. It identifies Elaia Partners and locations Paris, France / Belgium, and lists co-investor firms including Partech, XAnge, Khosla Ventures, Speedinvest and others. The retrieved page does not expose usable named team profiles, stage policy, check sizes or a dated fund amount. Co-investor associations do not prove a particular investment. Belgium should not be promoted to a current official office without additional evidence. Signal is undated, accessed 2026-10-06. ## Fund size and investment stages | Vehicle / metric | Amount and status | Dated supporting evidence and caveat | | --- | --- | --- | | Deep Tech Seed 3 (DTS3) | **€134 million final close**; first close was €60 million in March 2024 | Official release is dated **2026-03-12** in its [search-indexed PDF](https://www.elaia.com/wp-content/uploads/2026/03/DTS3-Final-Close-ENG.pdf); the [official HTML announcement](https://elaia.com/news/elaia-announces-final-close-of-dts3-at-134m) was directly read. The PDF itself returned a fetch error. This is a final close, superseding the early €120m target. | | Digital Venture 5 (DV5) | **€120 million first close**, not verified final size | [Official announcement](https://elaia.com/news/elaias-fifth-digital-venture-fund-dv5-announces-first-close-at-120m), HTML undated; [Maddyness, 2026-02-11](https://www.maddyness.com/2026/02/11/elaia-lance-un-nouveau-fonds-de-120-millions-deuros/) dates the first-close reporting. Official [PDF](https://www.elaia.com/wp-content/uploads/2026/02/DV5-First-Close-EN.pdf) was indexed but direct retrieval failed. No later final close verified. | | Digital Venture 4 (DV4) | **€200 million final close** | [EU-Startups, 2023-03-30](https://www.eu-startups.com/2023/03/elaia-closes-its-dv4-fund-at-e200-million-to-back-early-stage-b2b-tech-startups/). The historical [official PDF](https://www.elaia.com/wp-content/uploads/2023/03/DV4_PR_ENG.pdf) remains search-indexed but now redirects to a missing page. Earlier €120m commitments / €150m target are stale fundraising milestones, not final size. | | Firmwide AUM | **More than €1 billion**, reported with 2025 fundraising results | Lazard's [2026-06-16 announcement](https://www.lazardfreresgestion.com/fr/en_gb/about-us/news-and-press/funds-and-expertise/lazard-increases-stake-in-elaia-to-51) says Elaia raised €250m across funds in 2025 and surpassed €1bn AUM. Annual fundraising and AUM are separate metrics, neither an individual fund. | Latest-known individual vehicles checked are DTS3 and DV5; this is not a guarantee of exhaustive fund chronology. **DTS3 explicitly targets European B2B pre-seed and seed**, reporting investment amounts of €1m–€13m. **DV5 covers pre-seed through Series B** with stated tickets €1m–€15m for European B2B technology. These are fund-specific published ranges, not universally verified initial checks or whole-firm sweet spots. The broader homepage's pre-IPO positioning should not replace the early-stage mandates. DTS3's [official announcement](https://elaia.com/news/elaia-announces-final-close-of-dts3-at-134m) names computing, industry and life sciences as pillars; DV5's [official announcement](https://elaia.com/news/elaias-fifth-digital-venture-fund-dv5-announces-first-close-at-120m) supplies its stages and tickets. ## Verified named previous deep-tech investments All financing amounts below are total company rounds, not Elaia's contribution. Firm attribution is explicit, with fund attribution included only where supported. | Company | Technical rationale | Investment evidence / attribution | | --- | --- | --- | | **Alice & Bob** | Hardware for fault-tolerant quantum computing using cat qubits; defensible physical quantum technology. | Company announced **€100m Series B on 2025-01-28**, explicitly stating that Elaia Partners returned alongside other Series A investors. Leads were FFC, AVP and Bpifrance; do not label Elaia the lead. [Official announcement](https://alice-bob.com/newsroom/alice-bob-100m-series-b-fundraising-press-release/). | | **Proxima Fusion** | Stellarator fusion engineering, high-temperature superconductors and simulation-driven energy systems. | **€130m Series A closed 2025-06-11**; Elaia Partners explicitly named as a participating investor, with Cherry Ventures and Balderton co-leading. [Company release](https://www.proximafusion.com/press-news/proxima-fusion-raises-eu130m-series-a-to-build-worlds-first-stellarator-based-fusion-power-plant-in-the-2030s). Elaia's March 2026 [DTS3 announcement](https://elaia.com/news/elaia-announces-final-close-of-dts3-at-134m) identifies Proxima as a DTS3 portfolio company. | | **Biophta** | Patented biopolymer ophthalmic inserts providing sustained topical drug delivery; materials and drug-delivery development rather than ordinary health software. | Company reported **€6.5m seed closed**, published **2024-06-03**, co-led by Elaia, UI Investissement and GO Capital. [Official release](https://www.biophta.com/2024/06/03/biophta-raises-6-5-million-euros-seed-funding/). March 2026 DTS3 announcement also names it as a portfolio company. Vision/glaucoma care is adjacent to neurology, not proof of neural-interface investing. | | **Aqemia** | Quantum-inspired statistical mechanics combined with generative AI for drug design; scientific computational drug discovery. | Company statement **2020-07-01** reports **€1.6m raised in 2019 with Elaia Partners, business angels and Bpifrance**. Stage label and exact day of the 2019 round are not specified in this source. [Official company statement](https://aqemia.com/news/jean-marc-herbert-ex-sanofi-drug-discovery-vp-to-support-aqemias-rapid-growth-as-senior-advisor). This verifies historical firm attribution without relying on an unverified later round. | | **mimic robotics** | Physical AI applied to robotics; engineering-intensive automation. | Elaia explicitly names mimic as **DV5's first investment** in its [first-close release](https://elaia.com/news/elaias-fifth-digital-venture-fund-dv5-announces-first-close-at-120m), associated with February 2026 reporting. Amount, transaction date and Elaia's contribution are not supplied there; retain portfolio attribution without inferring a round. | ## Neurotech and adjacent investments **No verified neurotech investment found in the sources checked** when using the narrower definition of direct neural sensing, neural interfaces or neuromodulation. This is a bounded research result, not a claim that Elaia has never made such investments.
team@apexlogos.ai23 days ago
MATCH

Benoit Georis Elaia, venture_partner	$1M$100K – $5M	Belgium
Alexis Frentz Elaia, partner	$1M$100K – $5M	Paris, France
Anne-Sophie Carrese Elaia, partner	$1M$100K – $5M	Paris, France
Céline Passedouet Elaia, managing_director	$1M$100K – $5M	Paris, France
Franck Lescure Elaia, partner	$1M$100K – $5M	Paris, France
Marc Rougier Elaia, partner	$1M$100K – $5M	Paris, France
Pauline Roux Elaia, managing_partner	$1M$100K – $5M	Paris, France
Sofia Dahoune Elaia, partner	$1M$100K – $5M	Paris, France
Armelle de Tinguy Elaia, partner	—$100K – $5M	Paris, France
Florian Denis Elaia, partner	—$100K – $5M	Paris, France
Geoffroy De Meyer Elaia, analyst	—$100K – $5M	Paris, France
Manon Sorroche Elaia, analyst	—$100K – $5M	Paris, France
Philippe Gire Elaia, partner	—$100K – $5M	Paris, France
Samantha Jérusalmy Elaia, partner	—$100K – $5M	Paris, France
Xavier Lazarus Elaia, partner	—$100K – $5M	Paris, France
Anya Brochier Elaia, Marketing & Communications Senior Associate	—— – —
Arthur Liabastre Elaia, Senior Finance Officer	—— – —
Arturo Ancira García Elaia, Associate	—— – —
Camille Hamon Elaia, Finance Team Manager	—— – —
Celine Passedouet Elaia, Investment Director	—— – —
Christophe Primault Elaia, Venture Partner	—— – —
Clément Vanden Driessche Elaia, Partner	—— – —
Daniel Pilaud Elaia, Venture Partner	—— – —
David Sourdive Elaia, Venture Partner	—— – —
Delphine Villuendas Elaia, Partner, Head of Investor Relations	—— – —
Elfwa Ljungdahl Elaia, Associate	—— – —
Emma Aït Aoudia Elaia, Investor Relations Senior Associate	—— – —
Emmanuel Perez-Duarte Elaia, Partner, CFO & General Secretary	—— – —
Gabrielle de Massol Elaia, Associate	—— – —
Gemma Gil Romero Elaia, Office Manager	—— – —
Isabelle Amigues Elaia, Event Manager & Team Support	—— – —
Julien Macquet Elaia, Investment Manager	—— – —
Justine Guers Elaia, Chief of Staff, Head of Strategic Projects	—— – —
Laurent Kott Elaia, Venture Partner	—— – —
Loghan Lemonnier Elaia, Head of Digital Venture Operations	—— – —
Louis Darvoy-Lindrec Elaia, Finance Officer	—— – —
Louisa Mesnard Elaia, CMO, Head of Sustainability	—— – —
Léa Billaud Elaia, Investor Relations Associate	—— – —
Léonor Landeau Elaia, Investment Manager	—— – —
Pierre Besse Elaia, Head of Compliance, Internal Control & Risk	—— – —
Sacha Loiseau Elaia, Venture Partner	—— – —
Sandra Benacquista Elaia, Executive Assistant	—— – —
Seif Mahjoub Elaia, Analyst	—— – —
Sophie Digard Elaia, HR Director	—— – —
Sébastien Lefebvre Elaia, Partner	—— – —
Vincent Faber Elaia, Investment Director	—— – —
Xavier Evans Elaia, Sustainability Associate	—— – —
Zeevi Michel Elaia, Partner	—— – —

€411M2026-07-07	PROXIMA FUSION GMBH	Lightspeed, Burda Principal Investments, Cherry Ventures, UVC Partners, SPRIND, Bayern Kapital, Balderton Capital, Elaia, Redalpine
€411M2026-07-07	Proxima Fusion	Lightspeed, DCVC, Burda Principal Investments, Plural Platform, UVC Partners, SPRIND, Balderton Capital, Cherry Ventures, Elaia, Plural, Redalpine
$—2026-01-26	Aviwell	Elaia
$—2026	MyC	Elaia
$26M2025-11-18	GetVocal AI	Creandum, Hanel Baveja, Speedinvest, Elaia
$17M2025-11-17	Hummink	Elaia, Anne-Sophie Carrese
$16M2025-11-03	mimic robotics	Elaia, Speedinvest, 10x Founders
$100M2025-10-14	Dexory	Atomico, Elaia, Lakestar
$—2025-09-30	Vibe.co	Elaia
$12M2025-09-15	Seyna	Elaia, White Star Capital, Matthieu Lattes, Armelle de Tinguy
$—2025-08-06	Qbeast	Elaia
€130M2025-06-11	PROXIMA FUSION GMBH	Cherry Ventures, Balderton Capital, Lightspeed, Elaia, UVC Partners, Bayern Kapital, Club degli Investitori, HTGF, DeepTech & Climate Fonds, Plural, Leitmotif, Omnes Capital, Visionaries Tomorrow, Wilbe, Redalpine
€130M2025-06-11	Proxima Fusion	Cherry Ventures, Balderton Capital, Lightspeed, Plural Platform, UVC Partners, Bayern Kapital, Club degli Investitori, Elaia, Plural, Redalpine, Ian Hogarth, Daniel Waterhouse, Filip Dames
$—2025-02-20	Zymvol	Faber, Elaia
€100M2025-01-28	Alice & Bob	Elaia
$38M2024-12-10	Aqemia	Elaia
$—2024-10-10	Qantev	Elaia
$12M2024-09-26	SurgAR	Elaia, Céline Passedouet
$46M2024-09-02	Doccla	Lakestar, Elaia, Oliver Heimes
$11M2024-08-01	dottxt	Elaia
€6M2024-06-03	Biophta	Elaia
$—2024-05-28	NcodiN	Elaia, Earlybird Venture Capital
$220M2024-05-21	H AI	Creandum, Eurazeo, Accel, Motier Ventures, FirstMark Capital, Elaia, UiPath, Bpifrance Large Venture, Eric Schmidt, Xavier Niel, Amazon, Elaia Partners, Yuri Milner, Aglaé Ventures, Samsung Electronics, Visionaries Club
$220M2024-05-21	H	Creandum, Eurazeo, Angular Ventures, Accel, Motier Ventures, UI Path, Elaia
$—2024-04-24	FlexAI	Elaia
$—2024-02-01	Aqemia	Elaia
$11M2024	inHEART	Elaia
$—2024	Dunia	Elaia, Kindred Ventures, Redalpine
$—2024	Phospho	Y Combinator, Elaia
$25M2023-11-08	Tabnine	Khosla Ventures, Hearst Ventures, Atlassian Ventures, Headline, Elaia, Titanium Ventures
$—2023-10-10	HarfangLab	Elaia
$14M2023-08-01	Sonio	Elaia
$29M2023-06-28	Gleamer	Elaia
$13M2023-06-11	DJUST	Elaia
$37M2023-03-01	Sesamm	Elaia, Pauline Roux
$16M2023-02-28	Pili	Elaia, Franck Lescure
$—2023	dottxt	Elaia
$—2022-10-14	Namla	Elaia
$40M2022-09-14	CYREBRO	Elaia
$—2022-06-21	LynxCare	Elaia
$40M2022	CYREBRO	Elaia
$555M2021-09-21	Mirakl	Elaia, Felix Capital
$120M2021-04-21	Ornikar	Elaia, Philippe Gire
$18M2021-02-02	Holded	Elaia, Lakestar, Pauline Roux, Nicolas Brand
$—2021	Quantum Dice	Elaia, IP Group
$—2021	Elevo	Elaia
$300M2020-09-22	Mirakl	Bain Capital, Felix Capital, 83North, Elaia, Xavier Lazarus, Frederic Court
$23M2020-06-10	iBanFirst	Elaia, Breega
$—2020	Spectral TMS	Elaia
$—2020	Shipup	Elaia
$12M2020	CodeNotary	Elaia
$—2020	iBanFirst	Breega, Elaia
$—2019-06-20	PocketStudio	Elaia
$—2019-06-12	Hyperlex	Elaia
$60M2019-03-04	Shift	General Catalyst, Accel, Bessemer Venture Partners, Elaia, Iris Capital
$—2018-02-22	Tinyclues	Elaia
$—2018	Shipup	Elaia
$—2018	Hyperlex	Elaia
$28M2017-10-23	Shift	General Catalyst, Accel, Elaia, Iris Capital
$6M2017-04-11	Fretlink	Breega, Elaia
$—2016	Heuritech	Elaia
$3M2015	Marfeel	Elaia
$5M2013-10-22	Teads	Partech, Elaia Partners, Elaia
$8M2009	LogLogic	Sequoia, Sapphire Ventures, Elaia
$11MUnknown date	Traefik Labs	Elaia
$—Unknown date	Tilak	Elaia
$—Unknown date	The Hotels Network	Elaia
$—Unknown date	TakeTurns	Elaia
$—Unknown date	Sun Zu Lab	Elaia
$—Unknown date	Streambased	Elaia
$—Unknown date	SeqOne Genomics	Elaia
$—Unknown date	Quortex	Elaia
$—Unknown date	Primaa	Elaia
$—Unknown date	Nijta	Elaia
$1MUnknown date	Nano Corp	Elaia
$—Unknown date	Mablink Bioscience	Elaia
$9MUnknown date	Indeez	Elaia
$—Unknown date	I-Virtual	Elaia
$—Unknown date	hema.to	Elaia
$—Unknown date	Fentech	Elaia
$—Unknown date	Fabentech	Elaia
$—Unknown date	ENODIA THERAPEUTICS	Elaia
$—Unknown date	Easyrecrue	Elaia
$—Unknown date	Descartes&Mauss	Elaia
$—Unknown date	Corporatings	Elaia
$—Unknown date	Continuity	Elaia
$4MUnknown date	Composable	Elaia
$3MUnknown date	Cien	Elaia
$—Unknown date	Biophta	Elaia
$26MUnknown date	GetVocal	Creandum, Speedinvest, Elaia
$—2026-07-06	Aylight	Elaia
€10M2025-12-03	SIM&CURE	Elaia
$—2025-04-29	Azaleavision	Elaia
$11M2024-10-23	Dunia Innovations GmbH	Elaia, Redalpine, Kindred Ventures
$3M2024-04-25	Pixacare	Elaia
$—2023	Sesamm Sas	Elaia
$—2021	Minos Biosciences	Elaia
$—2018-11-12	Sancare	Elaia
$4M2017-05-23	Stanley Robotics	Elaia, Marc Rougier
$5M2013-10-22	Teads.tv	blisce/, Elaia
$—2008-06-19	NTRglobal	Elaia
$—Unknown date	SEQONE	Elaia
$—Unknown date	HEPHAISTOS Pharma	Elaia
$4MUnknown date	Cryptosense	Elaia

Funds3

Team

Co-investing

Investments